Skip to main content
Equibles
MMSI logo

MMSI · Merit Medical Systems Inc · Earnings Call Transcripts & Audio

Track MMSI — free

Use MMSI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MMSI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$86.34 +0.11 (+0.13%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.22B
Shares
59.71M
Volume · Oct 1 216.46K Avg daily vol (3M) 803.34K

Merit Medical Systems Inc Earnings Call Transcripts

Quarterly earnings calls for Merit Medical Systems Inc (MMSI), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲7.5% $287.18M $15.27M '22 Q3 22-10-26 ▲5.4% $293.42M $33.40M '22 Q4 23-02-22 ▲8% $297.56M $20.70M '23 Q1 23-06-08 ▲8.5% $320.06M $20.25M '23 Q2 23-07-25 ▲9.8% $315.23M $25.83M '23 Q3 23-10-26 ▲10.6% $324.51M $27.63M '23 Q4 24-02-28 ▲8.7% $323.51M $28.24M '24 Q1 24-04-30 ▲5.6% $338.00M $35.73M '24 Q2 24-09-18 ▲7.8% $339.85M $28.44M '24 Q3 24-10-30 ▲9.4% $355.16M $27.95M '24 Q4 25-02-25 ▲9.8% $355.35M $30.15M '25 Q1 25-04-24 ▲13.2% $382.46M $32.58M '25 Q2 25-07-30 ▲13% $384.16M $27.75M '25 Q3 25-10-30 ▲10.9% $393.94M $38.01M '25 Q4 26-02-24 ▲7.5% $381.88M $40.99M '26 Q1 26-04-30 LATEST ▲9.5% $418.84M $38.80M '26 Q2 26-07-30
Conference
Investor event
2026-09-23
Merit Medical Systems Inc (MMSI) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-22
Merit Medical Systems Inc (MMSI) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-10
Merit Medical Systems Inc (MMSI) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-11
Merit Medical Systems Inc (MMSI) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-30
Merit Medical Systems Inc (MMSI) Q2 2026 Earnings Call
Revenue
$418.84M
▲ 9.5% YoY
Diluted EPS
$0.65
▲ 20.4% YoY
Gross margin
51.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-08
Merit Medical Systems Inc (MMSI) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-30
Merit Medical Systems Inc (MMSI) Q1 2026 Earnings Call Transcript
Confident tone Viewpoint Medical Acquisition (Oncology) OEM / Medtronic Distribution Deal Endoscopy Platform Growth
Revenue
$381.88M
▲ 7.5% YoY
Diluted EPS
$0.68
▲ 38.8% YoY
Gross margin
48.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Merit Medical Systems Inc (MMSI) Q4 2025 Earnings Call Transcript
Confident tone Q4 and full year 2025 financial results Rhapsody product launch Cardiovascular segment
Revenue
$393.94M*
▲ 10.9% YoY
Gross margin
49.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2026-01-13
Merit Medical Systems Inc (MMSI) January 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-10-30
Merit Medical Systems Inc (MMSI) Q3 2025 Earnings Call Transcript
Positive tone Capital deployment and acquisitions Q3 financial results and guidance CEO transition and leadership
Revenue
$384.16M
▲ 13% YoY
Diluted EPS
$0.46
▼ 4.2% YoY
Gross margin
48.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
Merit Medical Systems Inc (MMSI) Q2 2025 Earnings Call Transcript
Positive tone 2025 Guidance WRAPSODY CIE Commercial Launch Q2 Financial Results
Revenue
$382.46M
▲ 13.2% YoY
Diluted EPS
$0.54
▼ 11.5% YoY
Gross margin
48.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
Merit Medical Systems Inc (MMSI) Q1 2025 Earnings Call Transcript
Confident tone Q1 revenue and earnings beat 2025 financial guidance update Geographic results and China risk
Revenue
$355.35M
▲ 9.8% YoY
Diluted EPS
$0.49
▲ 2.1% YoY
Gross margin
48.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Merit Medical Systems Inc (MMSI) Q4 2024 Earnings Call Transcript
Confident tone Q4 2024 results Geographic performance Cardiovascular and product categories
Revenue
$355.16M*
▲ 9.4% YoY
Gross margin
48.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-30
Merit Medical Systems Inc (MMSI) Q3 2024 Earnings Call Transcript
Confident tone Cook Medical Lead Management Acquisition Q3 Financial Results Beat China / APAC Region and VBP
Revenue
$339.85M
▲ 7.8% YoY
Diluted EPS
$0.48
▲ 9.1% YoY
Gross margin
46.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-09-18
Merit Medical Systems Inc (MMSI) Q2 2024 Earnings Call Transcript
Confident tone Quarterly financial results and beat China and volume-based purchasing (VBP) Leadership and governance changes
Revenue
$338.00M
▲ 5.6% YoY
Diluted EPS
$0.61
▲ 74.3% YoY
Gross margin
47.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
Merit Medical Systems Inc (MMSI) Q1 2024 Earnings Call Transcript
Confident tone Q1 financial results WRAPSODY WAVE study / FDA filing Cardiovascular and Peripheral Intervention growth
Revenue
$323.51M
▲ 8.7% YoY
Diluted EPS
$0.48
▲ 33.3% YoY
Gross margin
46.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Merit Medical Systems Inc (MMSI) Q4 2023 Earnings Call Transcript
Positive tone CGI Program & Three-Year Targets Margin Expansion Drivers Q4 Revenue Performance
Revenue
$324.51M*
▲ 10.6% YoY
Gross margin
46.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-26
Merit Medical Systems Inc (MMSI) Q3 2023 Earnings Call Transcript
Revenue
$315.23M
▲ 9.8% YoY
Diluted EPS
$0.44
▲ 63% YoY
Gross margin
45.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-25
Merit Medical Systems Inc (MMSI) Q2 2023 Earnings Call Transcript
Revenue
$320.06M
▲ 8.5% YoY
Diluted EPS
$0.35
▲ 29.6% YoY
Gross margin
47.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-06-08
Merit Medical Systems Inc (MMSI) Q1 2023 Earnings Call Transcript
Revenue
$297.56M
▲ 8% YoY
Diluted EPS
$0.36
▲ 100% YoY
Gross margin
46.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Merit Medical Systems Inc (MMSI) Q4 2022 Earnings Call Transcript
Revenue
$293.42M*
▲ 5.4% YoY
Gross margin
45.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-26
Merit Medical Systems Inc (MMSI) Q3 2022 Earnings Call Transcript
Revenue
$287.18M
▲ 7.5% YoY
Diluted EPS
$0.27
▲ 28.6% YoY
Gross margin
44.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-27
Merit Medical Systems Inc (MMSI) Q2 2022 Earnings Call Transcript
Revenue
$294.98M
▲ 5.2% YoY
Diluted EPS
$0.27
▲ 200% YoY
Gross margin
45.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Merit Medical Systems Inc (MMSI) Q1 2022 Earnings Call Transcript
Revenue
$275.42M
▲ 10.6% YoY
Diluted EPS
$0.18
▼ 5.3% YoY
Gross margin
43.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Merit Medical Systems Inc (MMSI) Q4 2021 Earnings Call Transcript
Revenue
$278.49M*
▲ 7.9% YoY
Gross margin
46.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Merit Medical Systems Inc (MMSI) Q3 2021 Earnings Call Transcript
Revenue
$267.02M
▲ 9.4% YoY
Diluted EPS
$0.21
Gross margin
45.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Merit Medical Systems Inc (MMSI) Q2 2021 Earnings Call Transcript
Revenue
$280.32M
▲ 28.4% YoY
Diluted EPS
$0.09
Gross margin
44.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Merit Medical Systems Inc (MMSI) Q1 2021 Earnings Call Transcript
Revenue
$248.91M
▲ 2.2% YoY
Diluted EPS
$0.19
Gross margin
45.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Merit Medical Systems Inc (MMSI) Q4 2020 Earnings Call Transcript
Revenue
$258.00M
▲ 0% YoY
Diluted EPS
$0.27
Gross margin
43.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-28
Merit Medical Systems Inc (MMSI) Q3 2020 Earnings Call Transcript
Revenue
$243.97M
▲ 0.4% YoY
Diluted EPS
$-0.05
Gross margin
41.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-29
Merit Medical Systems Inc (MMSI) Q2 2020 Earnings Call Transcript
Revenue
$218.37M
▼ 14.5% YoY
Diluted EPS
$-0.34
▼ 383.3% YoY
Gross margin
38.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-23
Merit Medical Systems Inc (MMSI) Q1 2020 Earnings Call Transcript
Revenue
$243.53M
▲ 2.2% YoY
Diluted EPS
$-0.06
▼ 154.5% YoY
Gross margin
42.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-24
Merit Medical Systems Inc (MMSI) Q4 2019 Earnings Call
Revenue
$257.92M
▲ 10.6% YoY
Diluted EPS
$-0.08
▼ 150% YoY
Gross margin
43.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–33 of 33 earnings calls
Key facts CIK 856982 CUSIP 589889104 13F (30d) 11 filings 9 filers Visit website Investor relations